Last reviewed · How we verify
NCT04942769
Study on the Effect of Selenium Supplementation on the Structure and Function of Autoimmune Thyroiditis
NA trial testing Selenium in Selenium in 30 participants. Status unknown.
30 July 2021
Quick facts
| Lead sponsor | Beijing Chao Yang Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 20 December 2019 |
| Primary completion | 30 July 2021 |
| Estimated completion | 30 October 2021 |
| Sites | 1 location across China |
Drugs / interventions tested
- Selenium (SELENIUM) — full drug profile →
Conditions studied
- Selenium — all drugs for Selenium →
Sponsor
Beijing Chao Yang Hospital
Who can join
Adults 18 to 75, any sex, with Selenium. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluate the effects of exogenous selenium supplementation on autoimmune thyroiditis.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Medical Applications of Molecular Biotechnologies in the Context of Hashimoto's Thyroiditis.
Trovato M, Valenti A. · · 2023 · cited 1× · PMID 37371008 · DOI 10.3390/diagnostics13122114
Verify or expand the search:
- PubMed search for NCT04942769
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Selenium
Trials testing the same drug.
- NCT07334197 — Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy · NA · not yet recruiting
- NCT05672095 — Niraparib and Selenium for the Treatment of Recurrent BRCA Negative Platinum Resistant Ovarian Cancer · Phase 1, PHASE2 · withdrawn
- NCT06413043 — Study on Efficacy of Add on Selenium in Mild-to-moderate Graves Ophthalmopathy · NA · not yet recruiting
- NCT06951282 — Impact of Selenium on Methotrexate Induced Spermatotoxicity; A Comparative Study · Phase 1, PHASE2 · completed
- NCT06362005 — The Efficacy of Selenium as an Alternative or Complementary Topical Treatment of Oral Lichen Planus · Phase 4 · completed
Other Beijing Chao Yang Hospital trials
Trials by the same sponsor.
- NCT07520305 — Efficacy Heterogeneity of Lactobacillus Paracasei LC19 on Type 2 Diabetes · NA · not yet recruiting
- NCT07490925 — Transpulmonary Pressure-guided Mechanical Ventilation Strategy in Right Ventricular Protection in Patients With ARDS · NA · not yet recruiting
- NCT07382986 — IMPACT COPD Cohort (China) · recruiting
- NCT07323134 — The Effect of Semaglutide on the Intestinal Flora in Obesity · not yet recruiting
- NCT07049692 — Hyperbaric Oxygen After Stroke Thrombectomy: A Multicenter Randomized Trial on Safety and Efficacy · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04942769 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Beijing Chao Yang Hospital
- Last refreshed: 16 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04942769.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing